CLINICAL_TRIALS
trial_result
· 2010-12-31
Clinical Trial Update: IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Cervical Dystonia [Phase 3]
Summary
A Phase 3 trial comparing Xeomin (incobotulinumtoxinA) to placebo for cervical dystonia has completed. Results were posted in 2010.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merz Pharmaceuticals GmbH | Conditions: Cervical Dystonia | Phase 3 | Status: COMPLETED | Results posted: 2010-12-31